A vaccine for dengue fever gets tested at Hopkins
A vaccine against dengue fever, a potentially serious flu-like infection that is on the rise, is undergoing tests at Johns Hopkins Bloomberg School of Public Health.
If it’s eventually proven effective, it could have far-reaching implications. About 2.5 billion people in more than 100 countries are at risk of such an infection – including some in the United States. It’s been discovered in Florida.
The vaccine has been in development for more than a decade at the National Institute of Allergy and Infectious Diseases and is finally ready for the first phase of clinical study – the safety phase. Dengue fever is caused by any of four viruses and is carried by Aedes mosquitoes. It infec